BioCentury
ARTICLE | Company News

Proteomics company Seer launches with $36M

December 17, 2018 12:02 PM UTC

Counting nanoparticle pioneer Omid Farokhzad, Robert Langer and Biogen Inc. (NASDAQ:BIIB) vet Philip Ma among its founders, proteomic data company Seer Inc. (South San Francisco, Calif.) launched Monday to develop liquid biopsy tests for early detection of multiple cancers and neurological diseases.

The company believes its nanosensor-based Proteograph platform could enable proteomics to catch up to genomics in scale and speed for routine testing of large populations...